Documents Reveal Government's 'Corruption and Wrongdoing'

In the U.S., the Food and Drug Administration is the foremost agency responsible for protecting public health. But an agency cannot look out for the public’s best interest if it is riddled with “systemic corruption and wrongdoing.” Those where the words used in a letter to the president of the United States, dated April 2, 2009, from the FDA’s Office of Device Evaluation.1 The letter’s signees have been redacted, but Sarah Kotler, the FDA’s director of the Division of Freedom of Information, who not only is privy to, but has custody of, official records from the FDA, said in a sworn affidavit that the letter is certified and authentic.2 It details that Dr. Frank M. Torti, who at the time was the FDA’s acting commissioner and first chief scientist, abruptly left the agency after the press revealed evidence of serious wrongdoing. However, “many other FDA managers who have failed to protect the American public” were not held accountable and remained in their positions, even after the following offenses:3 Violating laws, rules and regulations Suppressing or altering scientific or technological findings and conclusions Abusing their power and authority Engaging in illegal retaliation against those who speak out Top FDA Leaders Ignored Science and the Law In one example of wrongdoing, the letter describes a federal district court judge’s decision to overturn the FDA’s restrictions on the Plan B emergency contraception pill in order to make it available over-the-counter.4 The judge said the FDA’s decision to restrict access to the pill was “arbitrary and capricious because they were not the result of reasoned and good faith agency decision-making.”5 Instead of making a decision based on science, the FDA’s motives were political in nature and once again failed to put public health first, the letter alleges. Even top officials at the agency were pressured to conform to the agency’s motives or risk retaliation in the form of job loss or demotion. The letter reads: “FDA’s top leaders at the Center for Drug Evaluation and Research (CDER) testified that they ‘didn’t have a choice, and … [weren’t] sure that [they] would be allowed to remain [in their positions if they] didn’t agree’ to ignore the science and the law. To the contrary, they should be removed from their positions of authority precisely because they didn’t follow the science and the law. The judge further ruled that there was ‘unrebutted evidence that the FDA’s [decision] stemmed from political pressure rather than permissible health and safety concerns.’ The ‘improper political influence’ and the many ‘departures from its own policies’ reveal that such FDA officials are incapable of ensuring integrity and science at FDA.”6 Honest FDA Employees Fear the Dishonest Employee FDA physicians and scientists also wrote a letter in 2008 to the House Energy and Commerce Committee to advise that FDA officials had distorted the scientific review process of medical devices and then retaliated against those who spoke out. It came out in January 2009 that the FDA had approved a medical device to detect breast cancer even though FDA experts had advised against its approval on three separate occasions. The New York Times again described the actions as politically motivated, and FDA physicians described a culture of dishonesty and fear of reprisal. In a letter from FDA scientists to John Podesta, former White House Chief of Staff, dated January 7, 2009, it’s stated: “Through this letter and your action, we hope that future FDA employees will not experience the same frustration and anxiety that we have experienced for more than a year at the hands of FDA managers because we are committed to public integrity and were willing to speak out. Currently, there is an atmosphere at FDA in which the honest employee fears the dishonest employee, and not the other way around. Disturbingly, the atmosphere does not yet exist at FDA where honest employees committed to integrity and the FDA mission can act without fear of reprisal … America urgently needs change at FDA because FDA is fundamentally broken, failing to fulfill its mission, and because re-establishing a proper and effectively functioning FDA is vital to the physical and economic health of the nation.” After The New York Times and The Wall Street Journal published stories in 2009 detailing the FDA’s “improper political influence” and other wrongdoing, FDA attorneys and Torti sent an agency-wide email telling employees they “must comply with … obligations to keep certain information … confidential … [including] email to and from employees within FDA [that document the] deliberative process” and threatening that “violation … can result in disciplinary sanctions and/or individual criminal liability.” Further FDA documents show Torti and other top FDA officials attempted to cover up manipulations of the scientific review process for a knee implant medical devic

Documents Reveal Government's 'Corruption and Wrongdoing'

In the U.S., the Food and Drug Administration is the foremost agency responsible for protecting public health. But an agency cannot look out for the public’s best interest if it is riddled with “systemic corruption and wrongdoing.” Those where the words used in a letter to the president of the United States, dated April 2, 2009, from the FDA’s Office of Device Evaluation.1

The letter’s signees have been redacted, but Sarah Kotler, the FDA’s director of the Division of Freedom of Information, who not only is privy to, but has custody of, official records from the FDA, said in a sworn affidavit that the letter is certified and authentic.2

It details that Dr. Frank M. Torti, who at the time was the FDA’s acting commissioner and first chief scientist, abruptly left the agency after the press revealed evidence of serious wrongdoing. However, “many other FDA managers who have failed to protect the American public” were not held accountable and remained in their positions, even after the following offenses:3

  • Violating laws, rules and regulations
  • Suppressing or altering scientific or technological findings and conclusions
  • Abusing their power and authority
  • Engaging in illegal retaliation against those who speak out

Top FDA Leaders Ignored Science and the Law

In one example of wrongdoing, the letter describes a federal district court judge’s decision to overturn the FDA’s restrictions on the Plan B emergency contraception pill in order to make it available over-the-counter.4 The judge said the FDA’s decision to restrict access to the pill was “arbitrary and capricious because they were not the result of reasoned and good faith agency decision-making.”5

Instead of making a decision based on science, the FDA’s motives were political in nature and once again failed to put public health first, the letter alleges. Even top officials at the agency were pressured to conform to the agency’s motives or risk retaliation in the form of job loss or demotion. The letter reads:

“FDA’s top leaders at the Center for Drug Evaluation and Research (CDER) testified that they ‘didn’t have a choice, and … [weren’t] sure that [they] would be allowed to remain [in their positions if they] didn’t agree’ to ignore the science and the law.

To the contrary, they should be removed from their positions of authority precisely because they didn’t follow the science and the law.

The judge further ruled that there was ‘unrebutted evidence that the FDA’s [decision] stemmed from political pressure rather than permissible health and safety concerns.’ The ‘improper political influence’ and the many ‘departures from its own policies’ reveal that such FDA officials are incapable of ensuring integrity and science at FDA.”6

Honest FDA Employees Fear the Dishonest Employee

FDA physicians and scientists also wrote a letter in 2008 to the House Energy and Commerce Committee to advise that FDA officials had distorted the scientific review process of medical devices and then retaliated against those who spoke out. It came out in January 2009 that the FDA had approved a medical device to detect breast cancer even though FDA experts had advised against its approval on three separate occasions.

The New York Times again described the actions as politically motivated, and FDA physicians described a culture of dishonesty and fear of reprisal. In a letter from FDA scientists to John Podesta, former White House Chief of Staff, dated January 7, 2009, it’s stated:

“Through this letter and your action, we hope that future FDA employees will not experience the same frustration and anxiety that we have experienced for more than a year at the hands of FDA managers because we are committed to public integrity and were willing to speak out.

Currently, there is an atmosphere at FDA in which the honest employee fears the dishonest employee, and not the other way around. Disturbingly, the atmosphere does not yet exist at FDA where honest employees committed to integrity and the FDA mission can act without fear of reprisal …

America urgently needs change at FDA because FDA is fundamentally broken, failing to fulfill its mission, and because re-establishing a proper and effectively functioning FDA is vital to the physical and economic health of the nation.”

After The New York Times and The Wall Street Journal published stories in 2009 detailing the FDA’s “improper political influence” and other wrongdoing, FDA attorneys and Torti sent an agency-wide email telling employees they “must comply with … obligations to keep certain information … confidential … [including] email to and from employees within FDA [that document the] deliberative process” and threatening that “violation … can result in disciplinary sanctions and/or individual criminal liability.”

Further FDA documents show Torti and other top FDA officials attempted to cover up manipulations of the scientific review process for a knee implant medical device, in which a committee of outside experts were misled and manipulated. It was concealed, for instance, that one of the publications used to support the device was written, in part, by researchers with affiliations to the device manufacturer.7

Culture of Wrongdoing Is Longstanding

The patterns revealed in the letter reveal a longstanding pattern at the FDA, including the approval of medical devices against the opinions of scientific staff, even when the opinions were unanimous and in cases where the devices showed no clinical benefit and higher risks of death. The letter revealed:

“… on March 6, 2009, it was reported by the consumer advocacy organization Public Citizen that Dr. [Donna-Bea] Tillman [director of the Office of Device Evaluation] ‘approved a [medical] device that has failed to demonstrate any clinical benefit’ and that showed ‘trends toward higher risks of death.’

According to Public Citizen: The March 6, 2009 approval by Dr. Tillman ‘bears an eerie resemblance to another device, Intergel, an anti-scarring device intended for pelvic surgeries that also demonstrated reduced scarring without clinically validated outcomes. …

Less than two years after Intergel was approved [by Dr. Schultz], the company removed the product from the market due to reports of post-operative pain, foreign body reactions and tissue scarring requiring repeat surgery, including three deaths among women who received it. This history should have given the FDA pause before once again approving a similar device with a questionable safety record.”8

Perhaps it’s not surprising, then, that a revolving door also exists between FDA officials and Big Pharma — and a much-used one at that. Research published in The British Medical Journal (BMJ) suggests conflicts of interest are rampant, as a concerning number of FDA employees leave the agency to work for the drug industry.9

The researchers analyzed data on FDA hematology-oncology drug approvals from 2006 to 2010 along with medical reviews conducted from 2001 to 2010. They then discovered the subsequent jobs of the former FDA medical reviewers that worked on those drug approvals.

Out of 55 people, 15 left their job at the FDA to work or consult for the biopharmaceutical industry (another 29 continued working at the FDA in some capacity while the rest of the jobs could not be determined).

Cozy Ties Between the FDA and Big Pharma

Even past FDA Commissioners are likely to end up taking a position with the pharmaceutical industry. After leaving the top leadership position at the FDA, nine out of the last 10 commissioners in the past 33 years have gone on to work for pharmaceutical companies.

This stretch began when Arthur Hayes went on to join E.M. Pharmaceuticals in 1986 after resigning as commissioner in 1983.10 The last to join this group is the most recent FDA commissioner, Scott Gottlieb, who joined Pfizer as a member of their board.11

During his term at the FDA, Gottlieb pushed several policies intended to speed up drug approvals and use the power of the FDA12 to encourage greater use of biosimilars, or generic copied versions of more costly biologic drugs used to treat autoimmune diseases and some cancers.13

One manufacturer of biosimilar drugs is Pfizer, which had complained about perceived roadblocks to making these drugs more available. With Gottlieb on the board of directors at Pfizer, this may help the company navigate the FDA rules and regulations more easily.

Although the FDA has been in focus, other government agencies, including the U.S. Centers for Disease Control and Prevention, raise similar concerns.

In 2002 Dr. Julie Gerberding was the first woman to be appointed as a director for the CDC.14 While there she overhauled the structure of the organization causing many of the senior scientists and leaders to leave, as she replaced them with those who had ties to the vaccine industry.

During her years at the CDC, the FDA approved the Gardasil vaccine for human papilloma virus vaccination manufactured by Merck. In 2009, Gerberding left the CDC and later became the president of Merck’s vaccine division.15

Similar to the FDA, a group of senior CDC scientists in 2016 sent a letter to the CDC raising concerns about the conflicts of interest and industry ties that appear to be so common among CDC leaders.16 The letter specifically addresses several areas of “particular concern,” including:

  • A coverup of accurate screening data for the CDC’s Wise Woman Program. Despite, a multimillion-dollar investment, the number of women screened during the program fell short of expectations. Officials misrepresented actual screening numbers, “cooked” the data to make results “look better than they were” and manipulated data in “irregular ways.”
  • Resources allocated to domestic programs for Americans being directed toward global health and research issues.
  • A questionable relationship between Barbara Bowman, Ph.D., former director of the CDC’s Division for Heart Disease and Stroke Prevention, and Coca-Cola; she left the agency unexpectedly two days after her close ties with Coca-Cola were revealed.
  • Michael Pratt, senior adviser for Global Health in the National Center for Chronic Disease Prevention and Health Promotion at the CDC, has also allegedly promoted and led research for the soda giant.17

Meanwhile, while greenlighting drug approvals, the FDA has been targeting natural treatments like CBD oil and, rather than cracking down on the prescription opioids that are the root of the opioid epidemic, the FDA has gone after a natural plant called kratom.

Making Smart Health Decisions

When it comes to making health decisions for yourself and your family, it’s crucial to do your research from legitimate independent sources to get the truth. Due to rampant conflicts of interest, you can’t always blindly trust the health organizations that state they’re looking out for public health.

If you’re trying to address a health issue, make full use of all the resources available to you, including your own common sense, philosophical framework and reason. Ideally, you’ll also have a trusted holistic health care practitioner who can help to guide you and ensure you’re making positive choices to further your health at a foundational level.

Source : Mercola More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

IV High-Dose Vitamin C Saves Critically Ill COVID-19 Patient

While U.S. media and self-appointed “fact checkers” claim the use of vitamin C against COVID-19 is nothing but fake news and dangerous nonsense, the Chinese have been hard at work looking at vitamin C against this pandemic illness. One source where you can find pertinent research material is the Orthomolecular Medicine News Service website,1 which has published more than a dozen reports on this topic. Earlier this year I interviewed Dr. Andrew Saul, editor-in-chief of the Orthomolecular Medicine News Service, about vitamin C against viral illnesses such as COVID-19, in which he reviewed some of its established benefits. Importantly, vitamin C is an essential component of immune cell function, it has potent anti-inflammatory effects and at high doses even works as an antiviral. Vitamin C is a foundational component of two distinct and highly effective treatment protocols developed by Dr. Paul Marik — one for sepsis and another, called MATH+, specifically for COVID-19. I’ve reviewed both protocols in previous articles. COVID-19 Patient Brought From Brink of Death by Vitamin C An August 10, 2020, MedPage Today article2 highlights a recent case3 history in which high-dose IV vitamin C was successfully used to save the life of an elderly patient. A 74-year-old woman was admitted to a Flint, Michigan, hospital after suffering with low-grade fever, dry cough and shortness of breath for two days. She’d recently undergone a knee replacement procedure, and her knee is now red, swollen and painful, suggesting infection has set in. Over the next 24 hours, her condition continued to worsen, despite treatment with oxygen, antibiotics and other drugs. Her RT-PCR test also came back positive for SARS-CoV-2 infection. As reported by MedPage Today:4 “Clinicians start treatment with oral hydroxychloroquine 400 mg once and then 200 mg twice a day, along with intravenous azithromycin 500 mg once a day, zinc sulfate 220 mg three times a day, and oral vitamin C 1 g twice a day. When blood and sputum cultures are negative for any organisms, broad-spectrum antibiotics are discontinued. The patient's dyspnea rapidly worsens, and oxygen requirements increase to 15 liters. She is drowsy, in moderate distress, and her airways remain unprotected … By day 6 … Bilateral alveolar infiltrates are evident on chest x-ray, due to pneumonia and interstitial edema, consistent with acute respiratory distress syndrome (ARDS). Given her rapid deterioration, the patient is intubated on an emergent basis and started on pressure-regulated volume-controlled mechanical ventilation.” By day 7, the woman’s family requested she be placed on high-dose IV vitamin C, and over the next 24 hours, she received 11 grams total. Two days later, her condition began to gradually improve, and on day 10, a second chest x-ray revealed considerable improvement of both the pneumonia and interstitial edema, at which point she was extubated. The patient’s breathing continued improving over the following five days. “On day 16, she shows significant recovery, with oxygen saturation of 92% while breathing ambient air, and chest radiography reveals almost complete resolution of the infiltrates,” MedPage Today reports.5 “During her hospitalization, the patient received a total of 5 days of treatment with hydroxychloroquine and azithromycin along with 4 days of colchicine. Treatment with high-dose vitamin C infusion and oral zinc sulfate were continued for a total of 10 days.” Take-Home Message: Fight for the Treatment You Want Remarkably, while suffering from severe COVID-19 infection, septic shock and ARDS — and being on mechanical ventilation — this elderly woman made a full recovery. According to the doctors who reported the case, she was the first patient to successfully discontinue mechanical ventilation early at that hospital. The median duration of mechanical ventilation for COVID-19 patients is 10 days, whereas this patient was able to get off it in five. Vitamin C has been recognized as an essential component of immune cell function with a critical role in numerous immune system mechanisms. Severe vitamin C deficiency is also known to increase the risk for … pneumonia and other infections.A key take-home message from this story is that the IV infusion of vitamin C was done at the insistence of her family. It’s an excellent example demonstrating that when things are going sideways, you need to step in and push for the care you want. You have that right. It’s also an example of why it’s so important to have an advocate to speak up for you when you’re admitted to the hospital. This woman was placed on mechanical ventilation, which means she was sedated and was in no position to make any of her own decisions. Fortunately, her family knew about the potential benefits of vitamin C and insisted it be tried. In doing so, they saved her life. As noted by MedPage Today:6

IV High-Dose Vitamin C Saves Critically Ill COVID-19 Patient

While U.S. media and self-appointed “fact checkers” claim the use of vitamin C against COVID-19 is nothing but fake news and dangerous nonsense, the Chinese have been hard at work looking at vitamin C against this pandemic illness.

One source where you can find pertinent research material is the Orthomolecular Medicine News Service website,1 which has published more than a dozen reports on this topic.

Earlier this year I interviewed Dr. Andrew Saul, editor-in-chief of the Orthomolecular Medicine News Service, about vitamin C against viral illnesses such as COVID-19, in which he reviewed some of its established benefits. Importantly, vitamin C is an essential component of immune cell function, it has potent anti-inflammatory effects and at high doses even works as an antiviral.

Vitamin C is a foundational component of two distinct and highly effective treatment protocols developed by Dr. Paul Marik — one for sepsis and another, called MATH+, specifically for COVID-19. I’ve reviewed both protocols in previous articles.

COVID-19 Patient Brought From Brink of Death by Vitamin C

An August 10, 2020, MedPage Today article2 highlights a recent case3 history in which high-dose IV vitamin C was successfully used to save the life of an elderly patient.

A 74-year-old woman was admitted to a Flint, Michigan, hospital after suffering with low-grade fever, dry cough and shortness of breath for two days. She’d recently undergone a knee replacement procedure, and her knee is now red, swollen and painful, suggesting infection has set in.

Over the next 24 hours, her condition continued to worsen, despite treatment with oxygen, antibiotics and other drugs. Her RT-PCR test also came back positive for SARS-CoV-2 infection. As reported by MedPage Today:4

“Clinicians start treatment with oral hydroxychloroquine 400 mg once and then 200 mg twice a day, along with intravenous azithromycin 500 mg once a day, zinc sulfate 220 mg three times a day, and oral vitamin C 1 g twice a day.

When blood and sputum cultures are negative for any organisms, broad-spectrum antibiotics are discontinued. The patient's dyspnea rapidly worsens, and oxygen requirements increase to 15 liters. She is drowsy, in moderate distress, and her airways remain unprotected …

By day 6 … Bilateral alveolar infiltrates are evident on chest x-ray, due to pneumonia and interstitial edema, consistent with acute respiratory distress syndrome (ARDS). Given her rapid deterioration, the patient is intubated on an emergent basis and started on pressure-regulated volume-controlled mechanical ventilation.”

By day 7, the woman’s family requested she be placed on high-dose IV vitamin C, and over the next 24 hours, she received 11 grams total. Two days later, her condition began to gradually improve, and on day 10, a second chest x-ray revealed considerable improvement of both the pneumonia and interstitial edema, at which point she was extubated. The patient’s breathing continued improving over the following five days.

“On day 16, she shows significant recovery, with oxygen saturation of 92% while breathing ambient air, and chest radiography reveals almost complete resolution of the infiltrates,” MedPage Today reports.5

“During her hospitalization, the patient received a total of 5 days of treatment with hydroxychloroquine and azithromycin along with 4 days of colchicine. Treatment with high-dose vitamin C infusion and oral zinc sulfate were continued for a total of 10 days.”

Take-Home Message: Fight for the Treatment You Want

Remarkably, while suffering from severe COVID-19 infection, septic shock and ARDS — and being on mechanical ventilation — this elderly woman made a full recovery.

According to the doctors who reported the case, she was the first patient to successfully discontinue mechanical ventilation early at that hospital. The median duration of mechanical ventilation for COVID-19 patients is 10 days, whereas this patient was able to get off it in five.

push for the care you want. You have that right.

It’s also an example of why it’s so important to have an advocate to speak up for you when you’re admitted to the hospital. This woman was placed on mechanical ventilation, which means she was sedated and was in no position to make any of her own decisions. Fortunately, her family knew about the potential benefits of vitamin C and insisted it be tried. In doing so, they saved her life. As noted by MedPage Today:6

“Vitamin C in­fusion is not approved as a standard treatment for SARS-CoV-2 and thus was not part of the hospital's COVID-19 treatment regimen.

Nevertheless, the case authors point out that for decades, vitamin C has been recognized as an essential component of immune cell function with a critical role in numerous immune system mechanisms. Severe vitamin C deficiency is also known to increase the risk for … pneumonia and other infections.

Vitamin C enhances neutrophil motility, phagocytosis, microbial killing by activating reactive oxygen species, and apoptosis, and prevents oxidative damage by its antioxidant properties.

It also promotes the proliferation of B and T lymphocytes and antibody production. More recent research suggests that vitamin C also prevents the production of pro-inflammatory cytokines, including interleukin-6, a component of the cytokine release syndrome associated with severe COVID-19 that results in lung injury and leads to ARDS.”

Yes, Doctors Are Using Vitamin C Against COVID-19

While the U.S. media continues to censor claims that vitamin C can be useful against COVID-19, many practicing physicians and medical researchers are taking it seriously, primarily based on previous studies showing benefit against sepsis, viral illnesses and ARDS.

For example, in one 2019 trial7 involving 167 ICU patients with sepsis and ARDS, IV vitamin C at a dose of 50 mg per kilo every six hours for 96 hours significantly reduced mortality and shortened ICU stays.

At day 28, mortality was 46.3% in the placebo group compared to 29.8% in the vitamin C group, and the number of ICU-free days was 7.7 in the placebo group compared to 10.7 in the vitamin C group. The mean difference in ICU stay was 3.2 days.

Back in March 2020, Northwell Health, the largest hospital system in New York, also reported that vitamin C was being “widely used” against COVID-19 within its 23 hospitals, in conjunction with hydroxychloroquine and azithromycin (an antibiotic). As reported by the New York Post, March 24, 2020:8

“Seriously sick coronavirus patients in New York state’s largest hospital system are being given massive doses of vitamin C … Dr. Andrew G. Weber, a pulmonologist and critical-care specialist affiliated with two Northwell Health facilities on Long Island, said his intensive-care patients with the coronavirus immediately receive 1,500 milligrams of intravenous vitamin C.

Identical amounts of the powerful antioxidant are then re-administered three or four times a day, he said … The regimen is based on experimental treatments administered to people with the coronavirus in Shanghai, China …

The patients who received vitamin C did significantly better than those who did not get vitamin C,’ he said. ‘It helps a tremendous amount, but it is not highlighted because it’s not a sexy drug’ …

Weber … said vitamin C levels in coronavirus patients drop dramatically when they suffer sepsis, an inflammatory response that occurs when their bodies overreact to the infection. ‘It makes all the sense in the world to try and maintain this level of vitamin C,’ he said.”

COVID-19 Studies Underway

In China, improvements among COVID-19 patients receiving vitamin C have been so consistently observed that they’re actually looking into it as a stand-alone treatment.9 The trial,10 which began in February 2020, is expected to have results by the end of September 2020. As detailed in the clinical trial description:

“Vitamin C … has antioxidant properties. When sepsis happens, the cytokine surge caused by sepsis is activated, and neutrophils in the lungs accumulate in the lungs, destroying alveolar capillaries. Early clinical studies have shown that vitamin C can effectively prevent this process.

In addition, vitamin C can help to eliminate alveolar fluid by preventing the activation and accumulation of neutrophils, and reducing alveolar epithelial water channel damage. At the same time, vitamin C can prevent the formation of neutrophil extracellular traps, which is a biological event of vascular injury caused by neutrophil activation.”

Research is also underway at the Cleveland Clinic in Florida.11 Here, they will investigate whether newly diagnosed COVID-19 patients are less likely to require hospitalization when given vitamin C and zinc. They’ll also assess whether the combo might reduce disease severity and duration. The goal is to enroll 520 patients and start them on the supplements within two days of diagnosis. 

Vitamin C Recommendations and Guidance

For the actual treatment of sepsis and/or COVID-19, the dosages needed generally require IV administration. That said, Dr. Robert Rowen, whom I’ve interviewed about the use of vitamin C and ozone therapy for COVID-19, suggests taking upward of 6 grams (6,000 mg) per hour for acute illness, to simulate intravenous administration levels.

While doses higher than 20 grams per day of oral non-liposomal vitamin C typically result in loose stools, you can take up to 100 grams (100,000 mg) of liposomal or IV vitamin C without encountering such problems.

Prophylactically, it is not recommended to take such high doses, however. In fact, I discourage people from taking mega doses of vitamin C on a regular basis if they're not actually sick, because in high doses it is essentially a drug — or at least it works like one — and doing so could result in nutritional imbalances.

For example, taking large doses of vitamin C on a regular basis lowers your level of copper, so if you are already deficient in copper and take high doses of vitamin C, you can actually compromise your immune system. So, instead of taking it all the time, simply start mega-dosing at the first sign of symptoms of illness, and continue until symptoms recede.

Yet another alternative that I’m starting to think might be even better than vitamin C is nebulized hydrogen peroxide at 0.1% dilution. You can find more information about this in “Could Hydrogen Peroxide Treat Coronavirus?” I’ve recently come across examples of people with moderate to severe COVID-19 illness who rapidly recovered after this simple treatment. I’ll be discussing that in a future article.

Contraindications

The only contraindication to high-dose vitamin C treatment is if you are glucose-6-phosphate dehydrogenase (G6PD) deficient, which is a genetic disorder.12 G6PD is required for your body to produce NADPH, which is necessary to transfer reductive potential to keep antioxidants, such as vitamin C, functional.

Because your red blood cells do not contain any mitochondria, the only way it can provide reduced glutathione is through NADPH, and since G6PD eliminates this, it causes red blood cells to rupture due to inability to compensate for oxidative stress.

Fortunately, G6PD deficiency is relatively uncommon, and can be tested for. People of Mediterranean and African decent are at greater risk of being G6PD deficient. Worldwide, G6PD deficiency is thought to affect 400 million individuals, and in the U.S., an estimated 1 in 10 African-American males has it.13

Source : Mercola More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.